Market Commentary April 2012

Category: Market Commentary

30-04-2012

Read this month's Market Commentary newsletter which contains our view on the stock market based upon fundamental and technical analysis along with some recommended investments for the current market.

In the newsletter, we explain why we believe the market will, in all likelihood, trade in a trendless manner in the near future, based upon a variety of technical and fundamental factors.

We also highlight our preferred investments at this time including Astrazeneca (7.2x P/E & 7% yield), Balfour Beatty (7.4x P/E & 5.5% yield), Vodafone (11x P/E & 7.9% yield) and silver.

Read